Parrish Capital
JAZZ icon

Parrish Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Parrish Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$819K Buy
3,536
+354
+11% +$87.5K 0.8% 64
2026
Q2 		$767K Sell
3,182
-266
-8% -$58.3K 0.74% 64
2026
Q1 		$652K Buy
3,448
+407
+13% +$71.1K 0.58% 69
2025
Q4 		$517K Buy
+3,041
New +$466K 0.47% 74

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Arbejdsmarkedets Tillaegspension
Arbejdsmarkedets Tillaegspension Hilleroed $3.93B AUM 7.98% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Parrish Capital's JAZZ Position: Q3 2026 in Review

Parrish Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q3 2026, buying an estimated $87.5K and bringing the position to 3,536 shares worth $819K. The position accounts for 0.8% of the portfolio, ranked #64.

Parrish Capital first reported a position in JAZZ in Q4 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Parrish Capital held 3,536 shares of Jazz Pharmaceuticals worth $819K as of Q3 2026.
  • Parrish Capital bought 354 Jazz Pharmaceuticals shares in Q3 2026, an estimated $87.5K.
  • Jazz Pharmaceuticals made up 0.8% of Parrish Capital's portfolio in Q3 2026, its #64 holding.
  • Parrish Capital first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.